Inactivation of TNF/LT locus alters mouse metabolic response to concentrated ambient PM2.5

Toxicology. 2017 Sep 1:390:100-108. doi: 10.1016/j.tox.2017.09.009. Epub 2017 Sep 14.

Abstract

Background: Exposure to ambient fine particulate matter (PM2.5) is associated with increased cardiometabolic morbidity and mortality. This is widely believed to be attributable to PM2.5 exposure-induced pulmonary and subsequent systemic inflammation. Tumor necrosis factor alpha (TNFα), lymphotoxin α (LTα), and lymphotoxin β (LTβ) are three homologous pro-inflammatory cytokines, each with both unique and redundant activities in inflammation. Their role in PM2.5 exposure-induced inflammation and adverse cardiometabolic effects has to be determined.

Methods and results: LTα/TNFα/LTβ triple-knockout (TNF/LT KO) and wildtype (WT) mice were exposed to concentrated ambient PM2.5 (CAP) for 5 months. Lung pathological analysis revealed that TNF/LT deficiency reduced CAP exposure-induced pulmonary inflammation. However, glucose homeostasis assessments showed that TNF/LT deficiency significantly aggravated CAP exposure-induced glucose intolerance and insulin resistance. Consistent with glucose homeostasis assessments, CAP exposure significantly increased the body weight and adiposity of TNF/LT KO but not WT mice. In contrast to its body weight effects, CAP exposure reduced food intake of WT but not TNF/LT KO mice. On the other hand, CAP exposure induced marked fat droplet accumulation in brown adipose tissues of WT mice and significantly decreased their uncoupling protein 1 (UCP1) expression, and these effects were markedly exacerbated in TNF/LT KO mice.

Conclusion: The present study suggests that TNF/LT deficiency influences PM2.5 exposure-induced response of energy metabolism through alterations in both food intake and energy expenditure.

Keywords: Ambient PM(2.5); Inflammation; Lymphotoxin; Obesity; Tumor necrosis factor.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue, Brown / drug effects
  • Adipose Tissue, Brown / metabolism
  • Adipose Tissue, Brown / physiopathology
  • Adipose Tissue, White / drug effects
  • Adipose Tissue, White / metabolism
  • Adipose Tissue, White / physiopathology
  • Adiposity / drug effects
  • Animals
  • Biomarkers / blood
  • Blood Glucose / drug effects
  • Blood Glucose / metabolism
  • Eating / drug effects
  • Energy Metabolism / drug effects
  • Gene Silencing*
  • Genotype
  • Glucose Metabolism Disorders / chemically induced*
  • Glucose Metabolism Disorders / genetics
  • Glucose Metabolism Disorders / metabolism
  • Insulin / blood
  • Insulin Resistance
  • Lipid Droplets / drug effects
  • Lipid Droplets / metabolism
  • Lymphotoxin-alpha / deficiency*
  • Lymphotoxin-alpha / genetics
  • Lymphotoxin-beta / deficiency*
  • Lymphotoxin-beta / genetics
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Obesity / chemically induced*
  • Obesity / genetics
  • Obesity / metabolism
  • Obesity / physiopathology
  • Particle Size
  • Particulate Matter / toxicity*
  • Phenotype
  • Pneumonia / chemically induced
  • Pneumonia / genetics
  • Pneumonia / metabolism
  • Pneumonia / prevention & control*
  • Time Factors
  • Tumor Necrosis Factor-alpha / deficiency*
  • Tumor Necrosis Factor-alpha / genetics
  • Uncoupling Protein 1 / metabolism

Substances

  • Biomarkers
  • Blood Glucose
  • Insulin
  • Ltb protein, mouse
  • Lymphotoxin-alpha
  • Lymphotoxin-beta
  • Particulate Matter
  • Tumor Necrosis Factor-alpha
  • Ucp1 protein, mouse
  • Uncoupling Protein 1